LEGACY VENTURES INTERNATIONAL INC. (LGYV) Financial Statements (2024 and earlier)

Company Profile

Business Address 27 BAYCLIFFE RD.
MARKHAM, ON L3R 7T9
State of Incorp. NV
Fiscal Year End June 30
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,67821,01722,78015,13612,74530
Cash and cash equivalents1,67821,01722,78015,13612,74530
Prepaid expense509     
Total current assets:2,18721,01722,78015,13612,74530
Noncurrent Assets
TOTAL ASSETS:2,18721,01722,78015,13612,74530
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:38,60220,248140,609116,09792,76448,822
Interest and dividends payable 32,41811,8943,65117,609
Other undisclosed accounts payable and accrued liabilities38,60220,248108,191104,20389,11331,213
Debt   185,000120,00070,00052,425
Due to related parties 11,47337,67522,92522,92522,925
Other undisclosed current liabilities    11,894  
Total current liabilities:38,60231,721363,284270,916185,689124,172
Noncurrent Liabilities
Other undisclosed liabilities36,168 17,668 3,65117,609
Total liabilities:74,77031,721380,952270,916189,340141,781
Equity
Equity, attributable to parent(72,583)(10,704)(358,172)(255,780)(176,595)(141,751)
Common stock5,0325,03232323232
Additional paid in capital6,429,7716,429,7716,394,7716,394,7716,394,7716,394,771
Accumulated deficit(6,507,386)(6,445,507)(6,752,975)(6,650,583)(6,571,398)(6,536,554)
Total equity:(72,583)(10,704)(358,172)(255,780)(176,595)(141,751)
TOTAL LIABILITIES AND EQUITY:2,18721,01722,78015,13612,74530

Income Statement (P&L) (USD)

9/30/2023
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
Operating expenses(61,943)(54,822)(5,264)(8,863)(10,347)(35,205)
Other undisclosed operating loss   (46,900)(50,410)(50,850) 
Operating loss:(61,943)(54,822)(52,164)(59,273)(61,197)(35,205)
Nonoperating income (expense)64362,290(50,228)(29,912)26,353 
Gain, foreign currency transaction, before tax 229145    
Interest and debt expense  (13,363)(20,524)(8,243)(31,622)(511,617)
Income (loss) from continuing operations before equity method investments, income taxes:(61,879)294,105(122,916)(97,428)(66,466)(546,822)
Other undisclosed income (loss) from continuing operations before income taxes  13,36320,5248,24331,622(58,476)
Income (loss) from continuing operations:(61,879)307,468(102,392)(89,185)(34,844)(605,298)
Income (loss) before gain (loss) on sale of properties:307,468(102,392)(89,185)(34,844)(605,298)
Net income (loss):(61,879)307,468(102,392)(89,185)(34,844)(605,298)
Other undisclosed net loss attributable to parent      (20,000)
Net income (loss) available to common stockholders, diluted:(61,879)307,468(102,392)(89,185)(34,844)(625,298)

Comprehensive Income (USD)

9/30/2023
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
Net income (loss):(61,879)307,468(102,392)(89,185)(34,844)(605,298)
Comprehensive income (loss):(61,879)307,468(102,392)(89,185)(34,844)(605,298)
Other undisclosed comprehensive loss, net of tax, attributable to parent      (20,000)
Comprehensive income (loss), net of tax, attributable to parent:(61,879)307,468(102,392)(89,185)(34,844)(625,298)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: